Copyright Reports & Markets. All rights reserved.

Global In Situ Hybridization (ISH) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by In Situ Hybridization (ISH) Revenue
  • 1.4 Market by Type
    • 1.4.1 Global In Situ Hybridization (ISH) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Instruments
    • 1.4.3 Kits & Probes
    • 1.4.4 Software
    • 1.4.5 Services
  • 1.5 Market by Application
    • 1.5.1 Global In Situ Hybridization (ISH) Market Share by Application: 2020 VS 2026
    • 1.5.2 Cancer
    • 1.5.3 Cytogenetics
    • 1.5.4 Developmental Biology
    • 1.5.5 Infectious Diseases
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global In Situ Hybridization (ISH) Market Perspective (2015-2026)
  • 2.2 Global In Situ Hybridization (ISH) Growth Trends by Regions
    • 2.2.1 In Situ Hybridization (ISH) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 In Situ Hybridization (ISH) Historic Market Share by Regions (2015-2020)
    • 2.2.3 In Situ Hybridization (ISH) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 In Situ Hybridization (ISH) Market Growth Strategy
    • 2.3.6 Primary Interviews with Key In Situ Hybridization (ISH) Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top In Situ Hybridization (ISH) Players by Market Size
    • 3.1.1 Global Top In Situ Hybridization (ISH) Players by Revenue (2015-2020)
    • 3.1.2 Global In Situ Hybridization (ISH) Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global In Situ Hybridization (ISH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global In Situ Hybridization (ISH) Market Concentration Ratio
    • 3.2.1 Global In Situ Hybridization (ISH) Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by In Situ Hybridization (ISH) Revenue in 2019
  • 3.3 In Situ Hybridization (ISH) Key Players Head office and Area Served
  • 3.4 Key Players In Situ Hybridization (ISH) Product Solution and Service
  • 3.5 Date of Enter into In Situ Hybridization (ISH) Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global In Situ Hybridization (ISH) Historic Market Size by Type (2015-2020)
  • 4.2 Global In Situ Hybridization (ISH) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global In Situ Hybridization (ISH) Market Size by Application (2015-2020)
  • 5.2 Global In Situ Hybridization (ISH) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America In Situ Hybridization (ISH) Market Size (2015-2020)
  • 6.2 In Situ Hybridization (ISH) Key Players in North America (2019-2020)
  • 6.3 North America In Situ Hybridization (ISH) Market Size by Type (2015-2020)
  • 6.4 North America In Situ Hybridization (ISH) Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe In Situ Hybridization (ISH) Market Size (2015-2020)
  • 7.2 In Situ Hybridization (ISH) Key Players in Europe (2019-2020)
  • 7.3 Europe In Situ Hybridization (ISH) Market Size by Type (2015-2020)
  • 7.4 Europe In Situ Hybridization (ISH) Market Size by Application (2015-2020)

8 China

  • 8.1 China In Situ Hybridization (ISH) Market Size (2015-2020)
  • 8.2 In Situ Hybridization (ISH) Key Players in China (2019-2020)
  • 8.3 China In Situ Hybridization (ISH) Market Size by Type (2015-2020)
  • 8.4 China In Situ Hybridization (ISH) Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan In Situ Hybridization (ISH) Market Size (2015-2020)
  • 9.2 In Situ Hybridization (ISH) Key Players in Japan (2019-2020)
  • 9.3 Japan In Situ Hybridization (ISH) Market Size by Type (2015-2020)
  • 9.4 Japan In Situ Hybridization (ISH) Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia In Situ Hybridization (ISH) Market Size (2015-2020)
  • 10.2 In Situ Hybridization (ISH) Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia In Situ Hybridization (ISH) Market Size by Type (2015-2020)
  • 10.4 Southeast Asia In Situ Hybridization (ISH) Market Size by Application (2015-2020)

11 India

  • 11.1 India In Situ Hybridization (ISH) Market Size (2015-2020)
  • 11.2 In Situ Hybridization (ISH) Key Players in India (2019-2020)
  • 11.3 India In Situ Hybridization (ISH) Market Size by Type (2015-2020)
  • 11.4 India In Situ Hybridization (ISH) Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America In Situ Hybridization (ISH) Market Size (2015-2020)
  • 12.2 In Situ Hybridization (ISH) Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America In Situ Hybridization (ISH) Market Size by Type (2015-2020)
  • 12.4 Central & South America In Situ Hybridization (ISH) Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Thermo Fisher Scientific
    • 13.1.1 Thermo Fisher Scientific Company Details
    • 13.1.2 Thermo Fisher Scientific Business Overview
    • 13.1.3 Thermo Fisher Scientific In Situ Hybridization (ISH) Introduction
    • 13.1.4 Thermo Fisher Scientific Revenue in In Situ Hybridization (ISH) Business (2015-2020))
    • 13.1.5 Thermo Fisher Scientific Recent Development
  • 13.2 Leica BiosystemsNussloch GmbH
    • 13.2.1 Leica BiosystemsNussloch GmbH Company Details
    • 13.2.2 Leica BiosystemsNussloch GmbH Business Overview
    • 13.2.3 Leica BiosystemsNussloch GmbH In Situ Hybridization (ISH) Introduction
    • 13.2.4 Leica BiosystemsNussloch GmbH Revenue in In Situ Hybridization (ISH) Business (2015-2020)
    • 13.2.5 Leica BiosystemsNussloch GmbH Recent Development
  • 13.3 BIOVIEW
    • 13.3.1 BIOVIEW Company Details
    • 13.3.2 BIOVIEW Business Overview
    • 13.3.3 BIOVIEW In Situ Hybridization (ISH) Introduction
    • 13.3.4 BIOVIEW Revenue in In Situ Hybridization (ISH) Business (2015-2020)
    • 13.3.5 BIOVIEW Recent Development
  • 13.4 Agilent Technologies
    • 13.4.1 Agilent Technologies Company Details
    • 13.4.2 Agilent Technologies Business Overview
    • 13.4.3 Agilent Technologies In Situ Hybridization (ISH) Introduction
    • 13.4.4 Agilent Technologies Revenue in In Situ Hybridization (ISH) Business (2015-2020)
    • 13.4.5 Agilent Technologies Recent Development
  • 13.5 Merck KGaA
    • 13.5.1 Merck KGaA Company Details
    • 13.5.2 Merck KGaA Business Overview
    • 13.5.3 Merck KGaA In Situ Hybridization (ISH) Introduction
    • 13.5.4 Merck KGaA Revenue in In Situ Hybridization (ISH) Business (2015-2020)
    • 13.5.5 Merck KGaA Recent Development
  • 13.6 PerkinElmer Inc.
    • 13.6.1 PerkinElmer Inc. Company Details
    • 13.6.2 PerkinElmer Inc. Business Overview
    • 13.6.3 PerkinElmer Inc. In Situ Hybridization (ISH) Introduction
    • 13.6.4 PerkinElmer Inc. Revenue in In Situ Hybridization (ISH) Business (2015-2020)
    • 13.6.5 PerkinElmer Inc. Recent Development
  • 13.7 Bio-Rad Laboratories Inc.
    • 13.7.1 Bio-Rad Laboratories Inc. Company Details
    • 13.7.2 Bio-Rad Laboratories Inc. Business Overview
    • 13.7.3 Bio-Rad Laboratories Inc. In Situ Hybridization (ISH) Introduction
    • 13.7.4 Bio-Rad Laboratories Inc. Revenue in In Situ Hybridization (ISH) Business (2015-2020)
    • 13.7.5 Bio-Rad Laboratories Inc. Recent Development
  • 13.8 NeoGenomics Laboratories Inc.
    • 13.8.1 NeoGenomics Laboratories Inc. Company Details
    • 13.8.2 NeoGenomics Laboratories Inc. Business Overview
    • 13.8.3 NeoGenomics Laboratories Inc. In Situ Hybridization (ISH) Introduction
    • 13.8.4 NeoGenomics Laboratories Inc. Revenue in In Situ Hybridization (ISH) Business (2015-2020)
    • 13.8.5 NeoGenomics Laboratories Inc. Recent Development
  • 13.9 Advanced Cell Diagnostics Inc.
    • 13.9.1 Advanced Cell Diagnostics Inc. Company Details
    • 13.9.2 Advanced Cell Diagnostics Inc. Business Overview
    • 13.9.3 Advanced Cell Diagnostics Inc. In Situ Hybridization (ISH) Introduction
    • 13.9.4 Advanced Cell Diagnostics Inc. Revenue in In Situ Hybridization (ISH) Business (2015-2020)
    • 13.9.5 Advanced Cell Diagnostics Inc. Recent Development
  • 13.10 Oxford Gene Technology
    • 13.10.1 Oxford Gene Technology Company Details
    • 13.10.2 Oxford Gene Technology Business Overview
    • 13.10.3 Oxford Gene Technology In Situ Hybridization (ISH) Introduction
    • 13.10.4 Oxford Gene Technology Revenue in In Situ Hybridization (ISH) Business (2015-2020)
    • 13.10.5 Oxford Gene Technology Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    In Situ Hybridization (ISH) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In Situ Hybridization (ISH) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Thermo Fisher Scientific
    Leica BiosystemsNussloch GmbH
    BIOVIEW
    Agilent Technologies
    Merck KGaA
    PerkinElmer Inc.
    Bio-Rad Laboratories Inc.
    NeoGenomics Laboratories Inc.
    Advanced Cell Diagnostics Inc.
    Oxford Gene Technology

    Market segment by Type, the product can be split into
    Instruments
    Kits & Probes
    Software
    Services
    Market segment by Application, split into
    Cancer
    Cytogenetics
    Developmental Biology
    Infectious Diseases
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now